Evidence map›Paper›PMID 27384585›Full record

ReviewToxins2016

Ochratoxin A: 50 Years of Research.

Frantisek Malir, Vladimir Ostry, Annie Pfohl-Leszkowicz, Jan Malir, Jakub Toman

Open access · goldAbstract readHistorical ArticleReview
In one paragraph

Review in Toxins, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 177 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
177citing papers in PubMed, 3 pooled it
74.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

177 citing papers in PubMed, 3 syntheses or guidelines pooled it, 453 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

117 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Frantisek MalirDepartment of Biology, Faculty of Science, University of Hradec Kralove, Hradec Kralove 50003, Czech Republic. frantisek.malir@uhk.cz.
Vladimir OstryNational Reference Center for Microfungi and Mycotoxins in Food Chains, Center of Health, Nutrition and Food in Brno, National Institute of Public Health in Prague, Brno 61242, Czech Republic. ostry@chpr.szu.cz.
Annie Pfohl-LeszkowiczDepartment Bioprocess & Microbial Systems, Laboratory Chemical Engineering, INP/ENSA Toulouse, University of Toulouse, UMR 5503 CNRS/INPT/UPS, Auzeville-Tolosane 31320, France. leszkowicz@ensat.fr.
Jan MalirInstitute of State and Law, Czech Academy of Sciences, Narodni 18, Prague 11600, Czech Republic. jan.malir@ilaw.cas.cz.
Jakub TomanDepartment of Biology, Faculty of Science, University of Hradec Kralove, Hradec Kralove 50003, Czech Republic. jakub.toman.1@uhk.cz.
University of Hradec Králové · CZCzech Academy of Sciences, Institute of State and Law · CZÉcole Nationale Supérieure Agronomique de Toulouse · FRNational Institute of Public Health · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since ochratoxin A (OTA) was discovered, it has been ubiquitous as a natural contaminant of moldy food and feed. The multiple toxic effects of OTA are a real threat for human beings and animal health. For example, OTA can cause porcine nephropathy but can also damage poultries. Humans exposed to OTA can develop (notably by inhalation in the development of acute renal failure within 24 h) a range of chronic disorders such as upper urothelial carcinoma. OTA plays the main role in the pathogenesis of some renal diseases including Balkan endemic nephropathy, kidney tumors occurring in certain endemic regions of the Balkan Peninsula, and chronic interstitial nephropathy occurring in Northern African countries and likely in other parts of the world. OTA leads to DNA adduct formation, which is known for its genotoxicity and carcinogenicity. The present article discusses how renal carcinogenicity and nephrotoxicity cause both oxidative stress and direct genotoxicity. Careful analyses of the data show that OTA carcinogenic effects are due to combined direct and indirect mechanisms (e.g., genotoxicity, oxidative stress, epigenetic factors). Altogether this provides strong evidence that OTA carcinogenicity can also occur in humans.

Indexed as

Food MicrobiologyToxicologyAnimalsBalkan NephropathyCell Transformation, NeoplasticDNA DamageEpigenesis, GeneticGene Expression Regulation, NeoplasticHistory, 20th CenturyHistory, 21st CenturyHumansKidneyKidney NeoplasmsOchratoxinsOxidative StressRisk Assessmentochratoxin AOchratoxinsBalkan endemic nephropathybiomarkerscarcinogenicityfeedfoodmicrofungiochratoxin Atoxicityurothelial cancer

Identifiers

PMID27384585
PMCPMC4963825
OpenAlexW2466642275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.